bioAffinity Technologies (BIAF) Gains from Sales and Divestitures (2022 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Gains from Sales and Divestitures of $512.0 for Q1 2026, down 99.45% YoY from $92601.0 in Q1 2025, and down 92.88% sequentially from $7195.0 in Q4 2025.
bioAffinity Technologies (BIAF) Gains from Sales and Divestitures (2022 - 2026) Analysis & Trends
bioAffinity Technologies has disclosed Gains from Sales and Divestitures across 5 years of filings, most recently posting $512.0 for Q1 2026.
- In Q1 2026, Gains from Sales and Divestitures fell 99.45% year-over-year to $512.0; the TTM figure through Mar 2026 stood at $512.0 (down 99.45% YoY), while the FY2025 annual figure was $7195.0, down 5.59% from the prior year.
- Gains from Sales and Divestitures retreated to $512.0 in Q1 2026, from $7195.0 in the prior quarter.
- Over the last five years, Gains from Sales and Divestitures for BIAF reached as high as $172660.0 in Q2 2025 and fell as low as $106.0 in Q3 2024.
- The 5-year median for Gains from Sales and Divestitures is $7621.0 (2024), against an average of $35698.5.
- Annual changes were most pronounced in 2025 — Gains from Sales and Divestitures jumped 5209.43% — and 2026, when it slumped 99.45%.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $29728.0 in 2022, then soared by 98.64% to $59051.0 in 2023, then tumbled by 87.09% to $7621.0 in 2024, then retreated by 5.59% to $7195.0 in 2025, then slumped by 92.88% to $512.0 in 2026.
- According to Business Quant data, Gains from Sales and Divestitures over the past three periods registered $512.0, $7195.0, and $5628.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | bioAffinity Technologies | 3.78 Mn | 675,591.56 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 512.00 |
| Mar 31, 2026 | 512.00 |
| Dec 31, 2025 | 7,195.00 |
| Dec 31, 2025 | 7,195.00 |
| Sep 30, 2025 | 5,628.00 |
| Sep 30, 2025 | 5,628.00 |
| Jun 30, 2025 | 172,660.00 |
| Jun 30, 2025 | 172,660.00 |
| Mar 31, 2025 | 92,601.00 |
| Mar 31, 2025 | 92,601.00 |
| Dec 31, 2024 | 7,621.00 |
| Dec 31, 2024 | 7,621.00 |
| Sep 30, 2024 | 106.00 |
| Sep 30, 2024 | 106.00 |
| Jun 30, 2024 | 6,846.00 |
| Jun 30, 2024 | 6,846.00 |
| Mar 31, 2024 | 10,736.00 |
| Mar 31, 2024 | 10,736.00 |
| Dec 31, 2023 | 59,051.00 |
| Dec 31, 2023 | 59,051.00 |